Decheng Capital LLC Portfolio Holdings

Decheng Capital LLC

  • $356 Billion
  • Q1 2025

Decheng Capital LLC has filed its 13F form on May 07, 2025 for Q1 2025 where it was disclosed a total value porftolio of $356 Billion distributed in 27 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cg Oncology Inc with a value of $156B, Nuvation Bio Inc. with a value of $45.7B, Aardvark Therapeutics Inc with a value of $29.4B, Upstream Bio Inc. with a value of $20.1B, and Newamsterdam Pharma CO Nv Shs with a value of $15.8B.

Examining the 13F form we can see an decrease of $110B in the current position value, from $466B to 356B.

Decheng Capital LLC is based out at Menlo Park, CA

Below you can find more details about Decheng Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $356 Billion
Healthcare: $128 Billion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$25B
$1.82 Billion 0.51% of portfolio
20,000
Q1 2025 Reduced 50.0%
$14.3B
$932 Million 0.26% of portfolio
11,749
Q1 2025 Reduced 87.6%

Summary

  • Portfolio
  • No. of Stocks 27
  • Current Value $356 Billion
  • Prior Value $466 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 07, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 1 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Decheng Capital LLC Portfolio

Follow Decheng Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email